A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes

2010 ◽  
Vol 12 (12) ◽  
pp. 1113-1119 ◽  
Author(s):  
E. J. Rhee ◽  
W. Y. Lee ◽  
K. H. Yoon ◽  
S. J. Yoo ◽  
I. K. Lee ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Optimal Dose ◽  
Efficacy And Safety ◽  
Double Blind

Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial

2014 ◽  
Vol 31 (6) ◽  
pp. 621-638 ◽  
Author(s):  
Takashi Kadowaki ◽  
Masakazu Haneda ◽  
Nobuya Inagaki ◽  
Yasuo Terauchi ◽  
Atsushi Taniguchi ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Japanese Patients ◽  
Double Blind ◽  
Double Blind Placebo

Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone

2014 ◽  
Vol 30 (7) ◽  
pp. 1257-1266 ◽  
Author(s):  
Anil Pareek ◽  
Nitin Chandurkar ◽  
Nihal Thomas ◽  
Vijay Viswanathan ◽  
Alaka Deshpande ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Efficacy And Safety ◽  
Double Blind
Sign in / Sign up

Export Citation Format

Share Document